Twenty-four-week anti-PD-1 antibody regimen promoted HBsAg reduction and concurrently enhanced HBV-specific T cell responses in patients with chronic hepatitis B.

已完结 10 由达姆发布于 2026/4/2 10:02:51

DOI:10.1136/gutjnl-2025-336655
作者：Taiyu He,Min Chen,Maoying Liu,Li Zhang,Huidan Sun,Lu Zhang,Aoyi Li,Weiqun Zeng,Ning Ling,Xiaofeng Shi,Hua He,Mingli Peng,Dachuan Cai,Peng Hu,Dazhi Zhang,Yinghua Lan,Hong Ren
文献类型：期刊论文
补充材料：只需要正文

BMJ

Abstract：BACKGROUND PD-1 blockade has emerged as a promising approach for functional cure of chronic hepatitis B (CHB). OBJECTIVE This study aimed to evaluate the safety profile of anti-PD-1 ant

应助信息

1天前

脑子不缺水

c778e1952e3811f1b5f534735aa3bc31.pdf 已采纳

1天前

Book学术机器人

2026/4/2 10:02:51 未找到该文献，机器人已退出，请等待人工下载

2026/4/2 10:02:51 Book学术AI机器人收到请求，开始寻找文献

2026/4/2 10:02:51 已向机器人发送请求

1天前

达姆发布求助

上一个求助:其它数据库Naturally Fractured Carbonate Reservoir Characterization: A Case Study of a Mature High-Pour Point Oil Field in Hungary 下一个求助:ElsevierResearch on multimodal generative design of product appearance based on emotional and functional constraints